Delivery Order SPE2DB22D1106-SPE2DB25FFAZ1
- Not listed
- The Defense Logistics Agency awarded a $30,970.59 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Kineret 100 mg/0.67 ml syringes. This non-set-aside, firm fixed price delivery order is scheduled for completion by August 8, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Kineret (anakinra) is a recombinant interleukin-1 receptor antagonist used primarily for treating rheumatoid arthritis and...
- The Defense Logistics Agency awarded a $3,967.70 delivery order to Amerisourcebergen Drug Corporation for Kineret 100 mg/0.67 ml syringes. The firm fixed price order is for the delivery of pharmaceutical products to a location in Conshohocken, Pennsylvania, and has a period of performance from August 24, 2023 through September 15, 2023. As a major supplier of medical materiel to the U.S. Department of Defense, the Defense Logistics Agency utilizes contracts such as Amerisourcebergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,323.52 to AmerisourceBergen Drug Corp for the supply of Kineret 100 mg/0.67 mL syringes on July 23, 2025, with completion expected by August 13, 2025. This is a firm fixed-price delivery order issued under a competitively awarded indefinite delivery contract. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This award reflects no set-aside designation, indicating it...
- This federal contract award, valued at $1,614.32, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a leading global pharmaceutical distribution company, for the delivery of 4,564,159,150 units of the specialty pharmaceutical drug Kineret 100 mg/0.67 ml syringe. The contract has a firm fixed price and is a delivery order with an ultimate completion date of April 24, 2024. AmerisourceBergen Drug Corp, through its Corporate Office division located in Conshohocken,...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 4563267761 KINERET 100 MG/0.67 ML SYRINGE 0.67ML. The $4,842.96 delivery order will be performed at AmerisourceBergen's corporate office in Conshohocken, PA and has a completion date of January 30, 2024. This award was made without a set-aside designation....
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,371.32 firm fixed-price delivery order is for the provision of Kineret 100 mg/0.67 ml syringes. The contract has a period of performance through July 17, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency awarded a $4,761 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg/0.67 ml syringes of Kineret. The order is under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products to various Department of Defense components. Amerisourcebergen will deliver the Kineret syringes from its facility in Conshohocken, Pennsylvania by August 30th to fulfill this requirement placed by the Defense Logistics Agency....
- This is a $7,161.76 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of KINERET 100 MG/0.67 ML SYRINGE 0.67ML medical products, with a period of performance through April 9, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Kineret 100 mg/0.67 ml syringes. The fixed-price contract, valued at $4,476.10, has an ultimate completion date of April 8, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Kineret 100 mg/0.67 ml syringes. The $7,264.44 delivery order has a performance period ending on January 25, 2024. Amerisourcebergen Drug Corp is a prime contractor that frequently provides pharmaceutical products and medical supplies to support DLA's military treatment programs...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFAZ1Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for supply of Kineret (anakinra) 100 mg/0.67 mL syringes totaling $3,580.88 on July 31, 2025, with an ultimate completion date of August 21, 2025. This non-set-aside, firm fixed-price delivery order represents a pediatric or adult rheumatoid arthritis therapeutic supply under a competitive procurement process. The award was fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate office and primary distribution operations. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999.00 prime vendor agreement valued through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems worldwide. As a major pharmaceutical distributor, AmerisourceBergen regularly fulfills federal medical procurement requirements across multiple therapeutic domains for defense and veteran healthcare systems through competitively awarded contracts. The company's extensive federal contract portfolio demonstrates its capability to supply specialty medications, brand-name and generic pharmaceuticals, vaccines, and medical devices to support Defense Health Agency and other government healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 7/31/25 |